In another study, 17 diffuse large B-cell lymphoma (DLBCL) patients also received MGD013, and serum IFN-γ was significantly increased > 140-fold above baseline, as well as associated lytic markers (i.e., perforin and granzyme B) [89]. Here, PRF1 is linked to diffuse large B-cell lymphoma.